New radiopharmaceuticals, technologies, products, and software are driving adoption in an increasingly uncertain healthcare environment.

A new cloud-based platform utilizes wearable sensors to enable a patient to do physical therapy at home while a physical therapist remotely monitors their progress.

Researchers at Case Western Reserve University have combined a muscle from a sea slug’s mouth as well as bundles of its neurons and nerves with flexible 3D printed components to build biohybrid rob...

Francis Bitonti, Studio Bitonti, talks about the ways advanced design software has enabled generative design to flourish in the field of bioengineering in recent years. This algorithm-based method ...

Researchers at the Southwest Research Institute now are tackling the challenge of 3D-printing nonbiological parts that mimic the actual physical properties of human tissue.

Graphene-based neural sensors are showing promise in the treatment of brain disorders and injuries.

In the wake of recent developments in the field of cell therapy, bioprinter vendors are seeking to market to more sophisticated researchers.

A new breakthrough in anti-aging research could lead to gene and stem cell therapies that turn back the hands of time.

Testing drugs against patients’ cancer cells—without subjecting patients to chemotherapy—could lead to better, faster treatment.

Duke University researchers create breakthrough functional human heart muscle.

Using ultrasound, researchers at University California, San Diego, are working on a way to remotely control engineered T cells once they have been injected into patients for more targeted treatment.

Georgia Tech Engineers created an organization to develop standards and production processes designed to mass produce life-saving cell-based therapeutics at affordable prices. Via AABME

More bioengineers are taking a serious look at how virtual and augmented reality tools, like Microsoft's HoloLens can expand their design capabilities.

Researchers at the University of California Los Angeles bioengineering department developed a tissue-based soft robot that resembles a stingray.

Artificial mini guts that recreate the intestinal microbiome.

Join Marc Horner, Ph.D., Technical Lead, Healthcare at ANSYS, Inc. as he explains the concept of the digital twin and computational modeling as a critical element of modern healthcare in a free webina

A new nuclease inhibitor drug program could lead to the commercialization of novel DNA Damage Response treatments for female breast, ovarian, and other types of cancers.

Scientists successfully used CRISPR-Cas9 to repair a disease-causing genetic flaw in viable human embryos and prevent the mutation from being to future generations. What's next? Via AABME.org

Cellular Biomedicine Group, a clinical-stage biopharmaceutical company, recently partnered with GE Healthcare to produce therapies at scale for clinical trials. Via AABME

A medical device company has developed a portable device that can detect severe strokes within seconds. Via AABME.

A new microscope presents an unprecedented detailed picture of subcellular activity in 3D living color.

Medical device makers lag other industries in their use of computer models. One of the big issues is how much can researchers, regulators, and engineers trust their models and simulation?

Wyss Institute scientists have transformed CRISPR into a powerful mutation surveillance and disease prevention tool.

Biomedical firms that use modeling to make research and development decisions are looking to take take it to the next level.

A new device called Fiberscope could help scientists with their searches by giving them a less-invasive look into the brain’s depths.

Researchers create a "smart stent" to provide real-time feedback on blood flow to help decrease restenosis or the narrowing of arteries.

For the first time in medical history, a team of researchers has grown and sustained blood stem cells in a bioreactor.

A new approach to finding drug candidates for fighting cancers can drastically cut the time and money needed to evaluate millions of them.